MergerAug 11, 2026, 04:49 PM
MiMedx Group to Merge with Sanara MedTech; Corrects Termination Fees
AI Summary
MiMedx Group, Inc. has entered into a definitive Merger Agreement with Sanara MedTech Inc., under which Sanara will become a wholly-owned subsidiary of MiMedx. Each outstanding share of Sanara common stock will be converted into $33.00 in cash and 0.4735 shares of MiMedx Common Stock. Both companies' Boards of Directors have unanimously approved the merger. The filing also corrects previously reported termination fees, clarifying that Sanara's fee is $9,660,336.00 and MiMedx's fee is $22,540,785.00.
Key Highlights
- MiMedx Group, Inc. entered a Merger Agreement with Sanara MedTech Inc. on July 29, 2026.
- Sanara MedTech will become a wholly-owned subsidiary of MiMedx Group.
- Each Sanara share will convert into $33.00 cash and 0.4735 shares of MiMedx Common Stock.
- The stock consideration represents a value of $2.00 per share based on a 5-day average.
- Both MiMedx and Sanara Boards of Directors unanimously approved the Merger Agreement.
- Corrected termination fee for Sanara is $9,660,336.00, not $22,540,785.00.
- Corrected termination fee for MiMedx is $22,540,785.00, not $9,660,336.00.
Price Impact
More from MDXG